Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

MLA

Salmanton-García, Jon, et al. “Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis: Standard Treatment versus Posaconazole New Formulations (MoveOn).” The Journal of Antimicrobial Chemotherapy, vol. 74, no. 11, Nov. 2019, pp. 3315–27. EBSCOhost, https://doi.org/10.1093/jac/dkz344.

APA

Salmanton-García, J., Seidel, D., Koehler, P., Mellinghoff, S. C., Herbrecht, R., Klimko, N., Ráčil, Z., Falces-Romero, I., Ingram, P., Benítez-Peñuela, M.-Á., Rodríguez, J. Y., Desoubeaux, G., Barać, A., García-Vidal, C., Hoenigl, M., Mehta, S. R., Cheng, M. P., Klyasova, G., Heinz, W. J., … Vehreschild, M. J. G. T. (2019). Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). The Journal of Antimicrobial Chemotherapy, 74(11), 3315–3327. https://doi.org/10.1093/jac/dkz344

Chicago

Salmanton-García, Jon, Danila Seidel, Philipp Koehler, Sibylle C Mellinghoff, Raoul Herbrecht, Nikolai Klimko, Zdeněk Ráčil, et al. 2019. “Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis: Standard Treatment versus Posaconazole New Formulations (MoveOn).” The Journal of Antimicrobial Chemotherapy 74 (11): 3315–27. doi:10.1093/jac/dkz344.